Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
HUYA Bioscience International
HUYA Bioscience International
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
HUYA Bioscience appoints John Ratliff as President and CEO
He was previously President/COO of Quintiles' Global Services organisation
Pharmaceutical
HUYA Bioscience International expands senior management team
Recruits Dmitri Kharkevitch as Vice President for Clinical Development
Pharmaceutical
HUYA Bioscience International adds to senior management team
Yoshiki Shimamura joins the company as Vice President for Japan Operations
Pharmaceutical
HUYA Bioscience International strengthens executive team
Appoints Alain Rolland as Executive Vice President and Chief Scientific Officer
Research & Development
HUYA Bioscience and Zhongshan Technology Park form alliance
To accelerate discovery and development of biopharmaceuticals in China
Subscribe now